The principle behind Organogel implants?

Before injection, a hydrophilic organic solvent competes with organogelator molecules to inhibit gel formation. After injection, the diffusion of the solvent into the surrounding environment generates the self-aggregation of the organogelator molecules. The organogelator molecules help retain the hydrophobic organic liquid, making the composition shift from a liquid to a gel form. Hence, this provides a simple, spontaneous, in situ gelification process that is easy to administer. It is through a controlled process of diffusion and biodegradation that the implant formed in this way provides the controlled release of bioactive substances in the body.

Lipidic nanocapsules are prepared using a patented phase inversion process

This new colloidal system is comprised of a lipid core made up of medium chain triglycerides.  The lipid core is surrounded by phospholipids and hydrophilic polymers. This proprietary technique helps encapsulate lipophilic molecules as well as hydrophilic molecules.  For oral applications, the encapsulation of the active ingredient within the LNCs helps protect the molecule from degradation in the gastrointestinal environment, while increasing intestinal permeability. In particular, the LNCs can inhibit the activity of P-glycoprotein, the protein responsible for transporting many molecules. Ultimately, these properties help increase oral bioavailability..